An international, multistakeholder modified Delphi process was used to establish core outcome domain items for pyoderma gangrenosum clinical trials. Following three survey rounds and consensus meetings, 11 items reached final ratification, providing a standardized, patient-centered framework for outcome assessment and improved comparability across future trials.
No takes yet. Share an insight, caveat, or question.
Downey et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: